To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
1,759 Newest Market Studies of Global Markets Direct
rss
matching the following criteria
Diabetic Nephropathy – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Diabetic Nephropathy - Pipeline Review, H1 2012', provides an overview of the Diabetic Nephropathy therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special ...
Acute Respiratory Distress Syndrome – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Acute Respiratory Distress Syndrome - Pipeline Review, H1 2012', provides an overview of the Acute Respiratory Distress Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Acute Respiratory Distress ...
Dysmenorrhea – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H1 2012', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage ...
Hepatitis C – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H1 2012', provides an overview of the Hepatitis C therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage and ...
Glomerulonephritis – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Glomerulonephritis - Pipeline Review, H1 2012', provides an overview of the Glomerulonephritis therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special ...
Head And Neck Cancer – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Head and Neck Cancer - Pipeline Review, H1 2012', provides an overview of the Head and Neck Cancer therapeutic pipeline. This report provides information on the therapeutic development for Head and Neck Cancer, complete with latest updates, and special ...
Atrial Fibrillation – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Atrial Fibrillation - Pipeline Review, H1 2012', provides an overview of the Atrial Fibrillation therapeutic pipeline. This report provides information on the therapeutic development for Atrial Fibrillation, complete with latest updates, and special ...
Acute Ischemic Stroke – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Acute Ischemic Stroke - Pipeline Review, H1 2012', provides an overview of the Acute Ischemic Stroke therapeutic pipeline. This report provides information on the therapeutic development for Acute Ischemic Stroke, complete with latest updates, and ...
Ascites – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Ascites - Pipeline Review, H1 2012', provides an overview of the Ascites therapeutic pipeline. This report provides information on the therapeutic development for Ascites, complete with latest updates, and special features on late-stage and ...
Critical Limb Ischemia – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Critical Limb Ischemia - Pipeline Review, H1 2012', provides an overview of the Critical Limb Ischemia therapeutic pipeline. This report provides information on the therapeutic development for Critical Limb Ischemia , complete with latest updates, and ...
Netmeeting
